Effect of intraperitoneally administered propentofylline in a rat model of postoperative pain
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: In this study, we sought to evaluate whether systemic propentofylline (PPF) has antiallodynic effects in a rat model of postoperative pain, and to assess the mechanism involved. Methods: After plantar incision, rats were intraperitoneally injected with various doses of PPF to evaluate its antiallodynic effect. To investigate the involved mechanism, rats were intraperitoneally injected with yohimbine, dexmedetomidine, prazosin, naloxone, atropine or mecamylamine, following the incision of the rat hind paws, and then PPF was administered intraperitoneally. The mechanical withdrawal threshold (MWT) was evaluated using von Frey filaments at various time points and serum levels of tumor necrosis factor (TNF)-α, interleukin (IL)-1β, and IL-6 were measured to determine the inflammatory response level. Results: MWT was significantly increased after intraperitoneal injection of 30 mg/ kg of PPF when compared with the control group. Injection of PPF and yohimbine, atropine or mecamylamine showed significant decreases in the MWT, while injection of PPF and dexmedetomidine showed a significant increase. Systemic administration of PPF inhibited the post-incisional increase in serum level of TNF-α and IL- 1β. Conclusions: Systemic administration of PPF following surgery presented antiallodynic effects in a rat model of postoperative pain. The antiallodynic effects against mechanical allodynia could be mediated by α-adrenergic and cholinergic receptors.
Abstract
Background: In this study, we sought to evaluate whether systemic propentofylline (PPF) has antiallodynic effects in a rat model of postoperative pain, and to assess the mechanism involved. Methods: After plantar incision, rats were intraperitoneally injected with various doses of PPF to evaluate its antiallodynic effect. To investigate the involved mechanism, rats were intraperitoneally injected with yohimbine, dexmedetomidine, prazosin, naloxone, atropine or mecamylamine, following the incision of the rat hind paws, and then PPF was administered intraperitoneally. The mechanical withdrawal threshold (MWT) was evaluated using von Frey filaments at various time points and serum levels of tumor necrosis factor (TNF)-α, interleukin (IL)-1β, and IL-6 were measured to determine the inflammatory response level. Results: MWT was significantly increased after intraperitoneal injection of 30 mg/ kg of PPF when compared with the control group. Injection of PPF and yohimbine, atropine or mecamylamine showed significant decreases in the MWT, while injection of PPF and dexmedetomidine showed a significant increase. Systemic administration of PPF inhibited the post-incisional increase in serum level of TNF-α and IL- 1β. Conclusions: Systemic administration of PPF following surgery presented antiallodynic effects in a rat model of postoperative pain. The antiallodynic effects against mechanical allodynia could be mediated by α-adrenergic and cholinergic receptors.
참고문헌 (30)
- Apfelbaum JL, "Postoperative pain experience : results from a national survey suggest postoperative pain continues to be undermanaged", Anesth Analg, 97, pp.534~540 (2003)
- Gan TJ, "Incidence, patient satisfaction, and perceptions of post-surgical pain : results from a US national survey", Curr Med Res Opin, 30, pp.149~160 (2014)
- Chou R, "Management of postoperative pain : a clinical practice guideline from the American Pain Society, the American Society of Regional Anesthesia and Pain Medicine, and the American Society of Anesthesiologists’ Committee on Regional Anesthesia, Executive Committee, and Administrative Council", J Pain, 17, pp.131~157 (2016)
- Sweitzer S, "Propentofylline: glial modulation, neuroprotection, and alleviation of chronic pain", Handb Exp Pharmacol, (200), pp.235~250 (2011)
- Raghavendra V, "Antihyperalgesic and morphine-sparing actions of propentofylline following peripheral nerve injury in rats : mechanistic implications of spinal glia and proinflammatory cytokines", Pain, 104, pp.655~664 (2003)
- Tawfik VL, "Propentofyllineinduced astrocyte modulation leads to alterations in glial glutamate promoter activation following spinal nerve transection", Neuroscience, 152, pp.1086~1092 (2008)
- Ellis A, "Systemic administration of propentofylline, ibudilast, and(+)-naltrexone each reverses mechanical allodynia in a novel rat model of central neuropathic pain", J Pain, 15, pp.407~421 (2014)
- Gwak YS, "Propentofylline attenuates allodynia, glial activation and modulates GABAergic tone after spinal cord injury in the rat", Pain, 138, pp.410~422 (2008)
- Zhang J, "Tramadol and propentofylline coadministration exerted synergistic effects on rat spinal nerve ligation-induced neuropathic pain", PLoS One, 8, pp.e72943~ (2013)
- Brennan TJ, "Characterization of a rat model of incisional pain", Pain, 64, pp.493~501 (1996)
- Kilkenny C, "Improving bioscience research reporting : the ARRIVE guidelines for reporting animal research", PLoS Biol, 8, pp.e1000412~ (2010)
- Sluka KA, "Unilateral intramuscular injections of acidic saline produce a bilateral, long-lasting hyperalgesia", Muscle Nerve, 24, pp.37~46 (2001)
- 김의숙, "척수신경결찰 백서에서 Ketamine과 Ketorolac의 복강내 혼합주입이 기계적 이질통에 미치는 영향", Korean Journal of Anesthesiology, 46(6), pp.719~723 (2004), 대한마취통증의학회
- Macrae WA, "Chronic pain after surgery", Br J Anaesth, 87, pp.88~98 (2001)
- Sweitzer SM, "Propentofylline, a glial modulating agent, exhibits antiallodynic properties in a rat model of neuropathic pain", J Pharmacol Exp Ther, 297, pp.1210~1217 (2001)
- Jung S, "Propentofylline and iloprost suppress the production of TNF-alpha by macrophages but fail to ameliorate experimental autoimmune encephalomyelitis in Lewis rats", J Autoimmun, 10, pp.519~529 (1997)
- Sommer C, "Recent findings on how proinflammatory cytokines cause pain : peripheral mechanisms in inflammatory and neuropathic hyperalgesia", Neurosci Lett, 361, pp.184~187 (2004)
- Watkins LR, "Immune activation : the role of pro-inflammatory cytokines in inflammation, illness responses and pathological pain states", Pain, 63, pp.289~302 (1995)
- Colburn RW, "Dissociation of microglial activation and neuropathic pain behaviors following peripheral nerve injury in the rat", J Neuroimmunol, 79, pp.163~175 (1997)
- Schubert P, "Cascading glia reactions : a common pathomechanism and its differentiated control by cyclic nucleotide signaling", Ann N Y Acad Sci, 903, pp.24~33 (2000)
- Schubert P, "Support of homeostatic glial cell signaling : a novel therapeutic approach by propentofylline", Ann N Y Acad Sci, 826, pp.337~347 (1997)
- Clark IA, "How TNF was recognized as a key mechanism of disease", Cytokine Growth Factor Rev, 18, pp.335~343 (2007)
- Luo G, "IL1beta stimulates IL-6 production in cultured skeletal muscle cells through activation of MAP kinase signaling pathway and NF-kappa B", Am J Physiol Regul Integr Comp Physiol, 284, pp.R1249~54 (2003)
- Crassous PA, "Interest of alpha2-adrenergic agonists and antagonists in clinical practice : background, facts and perspectives", Curr Top Med Chem, 7, pp.187~194 (2007)
- Lavand’homme PM, "Perioperative administration of the alpha2-adrenoceptor agonist clonidine at the site of nerve injury reduces the development of mechanical hypersensitivity and modulates local cytokine expression", Pain, 105, pp.247~254 (2003)
- Schechtmann G, "Cholinergic mechanisms involved in the pain relieving effect of spinal cord stimulation in a model of neuropathy", Pain, 139, pp.136~145 (2008)
- Jessen Lundorf L, "Perioperative dexmedetomidine for acute pain after abdominal surgery in adults", Cochrane Database Syst Rev, 2, pp.CD010358~ (2016)
- Boyer KC, "A novel formulation of ketorolac tromethamine for intranasal administration : preclinical safety evaluation", Int J Toxicol, 29, pp.467~478 (2010)
- Chellman GJ, "Comparison of ketorolac tromethamine with other injectable nonsteroidal anti-inflammatory drugs for pain-on-injection and muscle damage in the rat", Hum Exp Toxicol, 13, pp.111~117 (1994)
- Malmberg AB, "Antinociceptive actions of spinal nonsteroidal anti-inflammatory agents on the formalin test in the rat", J Pharmacol Exp Ther, 263, pp.136~146 (1992)
